- September 21, 2022
Ensuring diverse representation to sustain legal innovation and change an industry
In the highly regulated and competitive biopharmaceutical industry, legal innovation is a critical driver of business success, guiding research and development (R&D), and matters of intellectual property (IP). Innovation in IP law is especially vital for a company like AbbVie, which has been at the forefront of R&D since its inception in 2013, investing almost … Continue reading Ensuring diverse representation to sustain legal innovation and change an industry →